KK

Kuldeep Kanaiyalal Ribadiya

Active Director Director DIN 06919929
DIN 06919929 First appointment Jul 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Jul 2015
Shareholding value •••• Premium profile

About Kuldeep Kanaiyalal Ribadiya

Data last updated:

Kuldeep Kanaiyalal Ribadiya is a Director at Symbiosis Bioscience Private Limited (since 2023) and Director at Axter Pharmaceuticals Private Limited (since 2015). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹7.55 Cr; the largest is Symbiosis Bioscience Private Limited at ₹4.13 Cr (FY 2025). Earlier, Kuldeep Kanaiyalal Ribadiya was a Director at Laxter Pharmaceuticals Private Limited (2019–2021).

DIN 06919929
Primary Designation Director
Industry Pharma
First Appointment 30 Jul 2015
Oldest Company Age 12 yrs
Largest company Symbiosis Bioscience Private Limited · ₹4.13 Cr (FY 2025)
Combined revenue ₹7.55 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Symbiosis Bioscience Private Limited U24304GJ2022PTC134050
Director17 Oct 20232022₹4.13 Cr (FY 2025)Active
Director30 Jul 20152014₹3.43 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 May 20192018₹1.51 Cr (FY 2023)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Axter Pharmaceuticals Private Limited
Symbiosis Bioscience Private Limited
Laxter Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kuldeep Kanaiyalal Ribadiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kuldeep Kanaiyalal Ribadiya

Kuldeep Kanaiyalal Ribadiya currently holds 2 directorships: Symbiosis Bioscience Private Limited (Director, since 17 Oct 2023, revenue ₹4.13 Cr (FY 2025)); Axter Pharmaceuticals Private Limited (Director, since 30 Jul 2015, revenue ₹3.43 Cr (FY 2025)).

Kuldeep Kanaiyalal Ribadiya was first appointed on 30 Jul 2015 as Director at Axter Pharmaceuticals Private Limited. The most recent appointment on record is 17 Oct 2023 at Symbiosis Bioscience Private Limited.

The 2 current companies of Kuldeep Kanaiyalal Ribadiya that report revenue have a combined latest revenue of ₹7.55 Cr: Symbiosis Bioscience Private Limited ₹4.13 Cr (FY 2025); Axter Pharmaceuticals Private Limited ₹3.43 Cr (FY 2025).

Kuldeep Kanaiyalal Ribadiya held 1 earlier board appointment: Laxter Pharmaceuticals Private Limited (Director, 09 May 2019 to 22 Jan 2021).

The current boards of Kuldeep Kanaiyalal Ribadiya's companies include Jagdish Pravinbhai Hirani (Symbiosis Bioscience Private Limited), Rushikumarkanaiyalal Ribadiya (Symbiosis Bioscience Private Limited), Sagar Pravinbhai Hirani (Symbiosis Bioscience Private Limited), Sakshi Laller (Symbiosis Bioscience Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available